NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer
30th July 2025 Uncategorised 0
Imfinzi and Imjudo combination recommended as first-line treatment

More: NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer
Source: News
